Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis

A Rebbapragada1, H Benchabane, J L Wrana

  • 1Department of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.

Insights

Myostatin negatively regulates muscle growth. This study reveals myostatin specifically inhibits bone morphogenetic protein 7 (BMP7)-induced adipogenesis by blocking receptor binding, highlighting its role in fat cell formation.

Area of Science:

  • Cell Biology
  • Endocrinology
  • Molecular Biology

Background:

  • Myostatin is a key negative regulator of skeletal muscle mass.
  • Bone morphogenetic proteins (BMPs) are involved in various cellular processes, including adipogenesis.
  • The interplay between myostatin and BMP signaling in adipogenesis is not fully understood.

Purpose of the Study:

  • To characterize the myostatin signal transduction pathway.
  • To investigate the effect of myostatin on BMP-induced adipogenesis.
  • To elucidate the molecular mechanism underlying myostatin's antagonism of BMP signaling.

Main Methods:

  • Utilized BMP-responsive reporter assays (I-BRE-Lux) to measure transcriptional activity.
  • Assessed adipogenic differentiation induced by BMP7 and BMP2.
  • Investigated receptor binding and complex formation using biochemical assays.
  • Characterized the myostatin signaling pathway involving ActRIIB, ALK4/ALK5, and Smad2/Smad3 phosphorylation.

Main Results:

  • Myostatin inhibited BMP7-induced adipogenesis but not BMP2-mediated responses.
  • Myostatin binds ActRIIB and partners with ALK4 or ALK5, activating a TGF-beta-like pathway.
  • Myostatin specifically prevented BMP7 binding to its receptors by competing for ActRIIB.
  • BMP7-induced heteromeric receptor complex formation was blocked by myostatin.

Conclusions:

  • Myostatin exhibits specific antagonism towards BMP7-mediated processes.
  • Myostatin plays a significant role in regulating adipogenesis.
  • The findings provide insights into the molecular mechanisms of myostatin's control over adipogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...